var data={"title":"Overview of chronic hemodialysis vascular access","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Overview of chronic hemodialysis vascular access</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributors\" class=\"contributor contributor_credentials\">Matthew J Oliver, MD, MHS</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributors\" class=\"contributor contributor_credentials\">Karen Woo, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributors\" class=\"contributor contributor_credentials\">Gerald A Beathard, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributors\" class=\"contributor contributor_credentials\">David L Cull, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributors\" class=\"contributor contributor_credentials\">Steve J Schwab, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributors\" class=\"contributor contributor_credentials\">Kathryn A Collins, MD, PhD, FACS</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The goal of chronic vascular access is to provide repetitive access to the circulation with minimal complications. Arteriovenous (AV) access, preferably AV fistulas, should be used when possible to avoid the risks associated with central venous catheters.</p><p>The types, general characteristics and a comparison of the types of AV hemodialysis access will be reviewed here. The use of central catheters for acute and chronic hemodialysis are reviewed separately. (See <a href=\"topic.htm?path=central-catheters-for-acute-and-chronic-hemodialysis-access\" class=\"medical medical_review\">&quot;Central catheters for acute and chronic hemodialysis access&quot;</a>.)</p><p>The management of failed AV access and other complications are discussed in separate topic reviews.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=failure-of-the-mature-hemodialysis-arteriovenous-fistula\" class=\"medical medical_review\">&quot;Failure of the mature hemodialysis arteriovenous fistula&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=hemodialysis-arteriovenous-graft-dysfunction-and-failure\" class=\"medical medical_review\">&quot;Hemodialysis arteriovenous graft dysfunction and failure&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=nonthrombotic-complications-of-arteriovenous-hemodialysis-access\" class=\"medical medical_review\">&quot;Nonthrombotic complications of arteriovenous hemodialysis access&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H568349\"><span class=\"h1\">RECOMMENDED STRATEGY FOR CHRONIC HEMODIALYSIS VASCULAR ACCESS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The preferred type of chronic hemodialysis vascular access is arteriovenous (AV) access, rather than hemodialysis catheters. Compared with AV hemodialysis access, hemodialysis catheter use has been consistently associated with worse complication and survival rates [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/1-4\" class=\"abstract_t\">1-4</a>]. </p><p>The United States Kidney Disease Outcomes Quality Initiative <span class=\"nowrap\">(K/DOQI)</span> guidelines recommend that chronic hemodialysis access catheters (more than three months in the absence of a maturing permanent access) should be used in less than 10 percent of prevalent patients who do not have a contraindication for permanent AV access, and that AV fistulas should be used in greater than 65 percent of prevalent patients [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"abstract_t\">5</a>].</p><p>Initial AV fistula use in the United States is still relatively low among incident patients but prevalent use has increased dramatically resulting in approximately 65 percent of patients using an AV fistula by one year of hemodialysis therapy [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/6\" class=\"abstract_t\">6</a>]. If an AV fistula is not possible, an AV graft can be considered. Hemodialysis catheters may be an acceptable option if all other forms of hemodialysis AV access have been exhausted, an AV fistula or graft is contraindicated (eg, severe heart failure), or if the expected duration of dialysis is less than one year. All patients who are eligible for an AV fistula or AV graft should be educated about the risks associated with hemodialysis catheters; but despite these risks, some well-informed patients will still prefer to use catheters for chronic dialysis access. (See <a href=\"topic.htm?path=central-catheters-for-acute-and-chronic-hemodialysis-access\" class=\"medical medical_review\">&quot;Central catheters for acute and chronic hemodialysis access&quot;</a>.)</p><p>An AV fistula is recommended over an AV graft for hemodialysis because a mature AV fistula has the lowest morbidity and mortality, lowest need for intervention, and the best long-term patency [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5,7-9\" class=\"abstract_t\">5,7-9</a>]. However, the relative benefit of fistulas may vary depending on the patient population, including age and comorbidities. Data from the Dialysis Morbidity and Mortality Study found no patency advantage of AV fistulas compared with AV grafts in older adult patients [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/10\" class=\"abstract_t\">10</a>], and a 2007 meta-analysis of 13 studies found that the 12-month primary and secondary patency rates of AV fistulas were lower in older adult patients compared with younger patients [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/11\" class=\"abstract_t\">11</a>]. Also, a study from the United States Renal Data System linked with Medicare claims showed that, for incident hemodialysis in patients &ge;67 years, there was no significant mortality difference between patients who had an AV graft placed as first access compared with those who had an AV fistula [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/12\" class=\"abstract_t\">12</a>]. A later review noted that the time to catheter-free dialysis was longer for AV fistulas compared with AV grafts in those &ge;75 years of age [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/13\" class=\"abstract_t\">13</a>].</p><p class=\"headingAnchor\" id=\"H4247039902\"><span class=\"h1\">ARTERIOVENOUS HEMODIALYSIS ACCESS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>To achieve a well-functioning arteriovenous (AV) access at the time of initiation of dialysis, timely referral for surgery is important. Sufficient lead time should be available for a careful preoperative evaluation and vascular mapping to help determine the best type and location of the access. Kidney Disease Outcomes Quality Initiative (K-DOQI) guidelines recommend that arterial and venous vascular mapping should be performed in all patients before placement of an access, with duplex ultrasound being the preferred method [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"abstract_t\">5</a>]. Routine preoperative ultrasound vein mapping may increase the prevalence of AV fistula creation [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/14-18\" class=\"abstract_t\">14-18</a>]. (See <a href=\"topic.htm?path=arteriovenous-fistula-creation-for-hemodialysis-and-its-complications\" class=\"medical medical_review\">&quot;Arteriovenous fistula creation for hemodialysis and its complications&quot;</a> and <a href=\"topic.htm?path=patient-evaluation-and-vascular-mapping-prior-to-placement-of-hemodialysis-arteriovenous-access\" class=\"medical medical_review\">&quot;Patient evaluation and vascular mapping prior to placement of hemodialysis arteriovenous access&quot;</a>.)</p><p>The minimum time for AV fistula maturation is one month, but a lead time of 6 to 12 months is recommended since intervention may be required to facilitate maturation of AV fistulas, particularly for patients with small vessels below the accepted thresholds for access creation [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"topic.htm?path=endovascular-intervention-for-the-treatment-of-stenosis-in-the-arteriovenous-access\" class=\"medical medical_review\">&quot;Endovascular intervention for the treatment of stenosis in the arteriovenous access&quot;</a>.) </p><p>In one study, AV fistulas created at least four months prior to starting hemodialysis were associated with a lower risk of sepsis and mortality [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/1\" class=\"abstract_t\">1</a>]. Much of the benefit was explained by the avoidance of central venous catheters. </p><p class=\"headingAnchor\" id=\"H2288150280\"><span class=\"h2\">Arteriovenous fistulas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AV fistula is a deliberate connection between a native artery and vein, and is typically constructed with an end-to-side vein-to-artery anastomosis. The most commonly used AV fistulas are created by anastomosing the radial artery to the cephalic vein (radiocephalic fistula) or by anastomosing the brachial artery to the cephalic vein (brachiocephalic fistula) or basilic vein (brachiobasilic fistula). Both Canadian and American guidelines prefer the radiocephalic AV fistula as the first choice for vascular access [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5,7\" class=\"abstract_t\">5,7</a>]. </p><p>Brachiocephalic and brachiobasilic AV fistulas are the second and third choices, respectively [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"abstract_t\">5</a>]. AV fistulas are less commonly created between the brachial artery and median antecubital vein [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/20\" class=\"abstract_t\">20</a>]. When native (autogenous) upper extremity veins are not suitable, AV access can also be constructed in the lower extremity, but these are uncommonly needed [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/21\" class=\"abstract_t\">21</a>]. (See <a href=\"topic.htm?path=arteriovenous-fistula-creation-for-hemodialysis-and-its-complications\" class=\"medical medical_review\">&quot;Arteriovenous fistula creation for hemodialysis and its complications&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H808138106\"><span class=\"h2\">Arteriovenous grafts</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AV grafts are constructed by interposing a prosthetic graft between an artery and vein, typically with expanded polytetrafluoroethylene (ePTFE) with a diameter of typically 6 mm (range: 4 to 8 mm). AV access can also be constructed from other biologic materials [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/22-25\" class=\"abstract_t\">22-25</a>]. The AV graft can be straight or looped. Prosthetic graft designs include those that are tapered (8 mm on one end, 4 mm on the other [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/26\" class=\"abstract_t\">26</a>]), thinner-walled [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/27\" class=\"abstract_t\">27</a>], or reinforced with rings for added support [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/28\" class=\"abstract_t\">28</a>]. When an AV graft is needed, the <span class=\"nowrap\">K/DOQI</span> work group supports a graft of either synthetic or biologic material [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"abstract_t\">5</a>]. (See <a href=\"topic.htm?path=arteriovenous-graft-creation-for-hemodialysis-and-its-complications\" class=\"medical medical_review\">&quot;Arteriovenous graft creation for hemodialysis and its complications&quot;</a>.) </p><p>Common graft locations are straight forearm (radial artery to cephalic vein), looped forearm (brachial artery to cephalic vein), straight upper arm (brachial artery to axillary vein), or looped upper arm (axillary artery to axillary vein). The <span class=\"nowrap\">K/DOQI</span> work group suggests a preference for a forearm loop graft rather than a straight configuration [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"abstract_t\">5</a>]. Lower extremity grafts, looped chest grafts, axillary-axillary (necklace) grafts, and axillary-atrial grafts have also been constructed, but are uncommon [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/29,30\" class=\"abstract_t\">29,30</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">COMPARISON OF AV FISTULAS AND AV GRAFTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Arteriovenous (AV) fistulas and AV grafts differ according to failure rates, time to use, patency, and perioperative and long-term complications. These differences form the basis for the recommendations for AV fistulas over AV grafts, whenever possible. (See <a href=\"#H568349\" class=\"local\">'Recommended strategy for chronic hemodialysis vascular access'</a> above.) </p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Primary failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AV fistulas are more likely than AV grafts to experience primary failure, which can be generally defined as an AV access that never provided reliable access for hemodialysis. Risk factors for primary failure of AV fistulas include wrist fistula, and those patients who are older, obese, nonwhite, female, diabetic, <span class=\"nowrap\">and/or</span> have peripheral artery or coronary heart disease [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/31-43\" class=\"abstract_t\">31-43</a>]. (See <a href=\"topic.htm?path=primary-failure-of-the-hemodialysis-arteriovenous-fistula#H60136735\" class=\"medical medical_review\">&quot;Primary failure of the hemodialysis arteriovenous fistula&quot;, section on 'Risk factors'</a> and <a href=\"topic.htm?path=risk-factors-for-hemodialysis-arteriovenous-fistula-failure\" class=\"medical medical_review\">&quot;Risk factors for hemodialysis arteriovenous fistula failure&quot;</a>.) </p><p>A systematic review pooled rates of AV fistula failure [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/44\" class=\"abstract_t\">44</a>]. The pooled estimate among 7292 AV fistulas was 23 percent. Failure rates for lower arm AV fistulas were significantly higher compared with upper arm AV fistulas (28 versus 20 percent). Patients 65 years and older also had a significantly higher primary failure rate compared with younger patients (37 versus 27 percent). These authors also noted a significant decrease in primary failure rates in later studies. However, some have reported an increased rate of primary failure, speculated to be due to the increased incidence of AV fistula creation as a result of the Fistula First initiative. One study found that the primary failure of AV fistulas increased from 14 to 36 percent when the rate of attempted AV fistula in incident dialysis patients increased from 38 to 72 percent [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/45\" class=\"abstract_t\">45</a>]. Another report noted similar outcomes when AV fistulas were attempted in 54 percent of incident patients, reporting primary failure rates of 66 and 41 percent for radiocephalic and brachiocephalic, respectively [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/31\" class=\"abstract_t\">31</a>]. </p><p>With respect to AV grafts, the Kidney Disease Outcomes Quality Initiative <span class=\"nowrap\">(K/DOQI)</span> guidelines suggest that the primary AV access failure rates should be no more than the following [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"abstract_t\">5</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>10 percent with forearm loop grafts</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>15 percent with forearm straight grafts</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>5 percent with upper arm grafts</p><p/><p>Intervention may be needed to promote maturation and reduce the risk of primary failure [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5,46-53\" class=\"abstract_t\">5,46-53</a>]. (See <a href=\"topic.htm?path=primary-failure-of-the-hemodialysis-arteriovenous-fistula#H215935147\" class=\"medical medical_review\">&quot;Primary failure of the hemodialysis arteriovenous fistula&quot;, section on 'Treatment of specific lesions'</a> and <a href=\"topic.htm?path=primary-failure-of-the-hemodialysis-arteriovenous-fistula#H67648891\" class=\"medical medical_review\">&quot;Primary failure of the hemodialysis arteriovenous fistula&quot;, section on 'Outcomes for fistula salvage'</a> and <a href=\"topic.htm?path=hemodialysis-arteriovenous-graft-dysfunction-and-failure#H852999487\" class=\"medical medical_review\">&quot;Hemodialysis arteriovenous graft dysfunction and failure&quot;, section on 'Treatment of stenosis'</a> and <a href=\"topic.htm?path=hemodialysis-arteriovenous-graft-dysfunction-and-failure#H402952213\" class=\"medical medical_review\">&quot;Hemodialysis arteriovenous graft dysfunction and failure&quot;, section on 'Treatment of thrombosis'</a>.) </p><p class=\"headingAnchor\" id=\"H571247\"><span class=\"h2\">Patency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although AV fistulas have a high early risk of primary failure, long-term patency of those that have matured is superior to that of AV grafts. In studies evaluating patency rates [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/44,54-56\" class=\"abstract_t\">44,54-56</a>], it is often difficult to determine whether primary failure has been included or excluded (often, it is included). (See <a href=\"#H8\" class=\"local\">'Primary failure'</a> above.)</p><p>The rate of primary failure can be as high as 33 percent for fistulas. By comparison, AV grafts have very low primary failure rates at approximately 5 percent. Thus, when comparing AV fistulas with AV grafts, it is important to remember that AV fistulas start at a lower baseline patency rate (66 rather than 100 percent); however, because AV graft patency declines at a faster rate, the patency curves cross at approximately two years. As a result, the benefits of the AV fistula over the AV graft are not fully realized until the early risk of primary AV fistula failure is absorbed. Since the median survival of hemodialysis patients is approximately three years, many patients will not realize the benefit of AV fistulas because they do not live long enough. With these considerations in mind, representative AV fistula and AV graft patencies are illustrated in a systematic review that included AV fistulas and AV grafts [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/54\" class=\"abstract_t\">54</a>]. Patencies at two years were as follows:</p><p>For AV fistulas: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary patency: 55 percent </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary patency: 63 percent</p><p/><p>For AV grafts: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary patency: 40 percent </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary patency: 60 percent</p><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Time to first cannulation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The time to use is longer following the creation of AV fistulas compared with AV grafts. AV grafts can usually be cannulated within three to six weeks. Advances in AV graft design may allow routine cannulation within 24 to 72 hours of placement [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/57,58\" class=\"abstract_t\">57,58</a>]. Overall, the findings discussed below suggest that AV fistulas should be allowed to mature for at least 30 days. (See <a href=\"topic.htm?path=maturation-and-evaluation-of-the-newly-created-hemodialysis-arteriovenous-fistula#H2190020270\" class=\"medical medical_review\">&quot;Maturation and evaluation of the newly created hemodialysis arteriovenous fistula&quot;, section on 'Timing'</a>.) </p><p>Although some AV fistulas may be ready for cannulation at 30 days, a longer time (up to six months) may be needed before they provide reliable hemodialysis access. The time to first cannulation varies widely by country. In observational studies, the median time to first cannulation in Japan and Italy is reported as 30 days, whereas, in the United States and United Kingdom, it is reported as almost 100 days [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/38,59-62\" class=\"abstract_t\">38,59-62</a>]. In an Italian study, the median time to first cannulation was also approximately one month, but ranged between 3 days to 28 months [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/38\" class=\"abstract_t\">38</a>]. </p><p>In the Italian study, on multivariate analysis, a predictor of primary AV fistula failure included cannulation earlier than one month. More specifically, every two-week increase in maturation time was associated with a 5 percent decrease in probability of primary failure [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/38\" class=\"abstract_t\">38</a>]. However, in another study, cannulation of AV fistulas any time after 14 days was not associated with an increased risk of failure, suggesting that AV fistulas may be used sooner than previously thought in selected patients [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/60\" class=\"abstract_t\">60</a>]. Similar findings related to success with early cannulation were reported in a second study from the Dialysis Outcomes and Practice Patterns Study (DOPPS) database [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/61\" class=\"abstract_t\">61</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common complications of AV fistulas and AV grafts include thrombosis, infection, access-related hand ischemia (vascular steal syndrome), aneurysmal dilation, venous hypertension, seroma, heart failure, and local bleeding. Thrombosis, infection, and seromas occur more frequently with AV grafts compared with AV fistulas.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>DOPPS found that AV grafts are 3.8 times more likely to require a thrombectomy and three times more likely to require access intervention than AV fistulas [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/63\" class=\"abstract_t\">63</a>]. (See <a href=\"topic.htm?path=hemodialysis-arteriovenous-graft-dysfunction-and-failure\" class=\"medical medical_review\">&quot;Hemodialysis arteriovenous graft dysfunction and failure&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The risk of infection for AV grafts averages 10 percent over their duration of use, compared with 5 percent for transposed AV fistulas, and less than 2 percent for nontransposed AV fistulas [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/47,64-67\" class=\"abstract_t\">47,64-67</a>]. Graft infection may require complete excision to eradicate the infection, while AV fistula infections may resolve with intravenous antibiotics. (See <a href=\"topic.htm?path=nonthrombotic-complications-of-arteriovenous-hemodialysis-access\" class=\"medical medical_review\">&quot;Nonthrombotic complications of arteriovenous hemodialysis access&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>True aneurysms and pseudoaneurysms are relatively common at sites of repeated cannulation or where the vein wall or AV graft has become thinned [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/68,69\" class=\"abstract_t\">68,69</a>]. Rotating cannulation sites should reduce the risk of this complication. Using the button-hole technique to cannulate AV fistulas may also reduce the risk of this complication. (See <a href=\"topic.htm?path=nonthrombotic-complications-of-arteriovenous-hemodialysis-access\" class=\"medical medical_review\">&quot;Nonthrombotic complications of arteriovenous hemodialysis access&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Symptomatic access-related hand ischemia complicates up to 20 percent of patients receiving an upper extremity access, but is more likely to occur in upper arm (eg, brachiocephalic fistulas [6 percent risk]) compared with forearm fistulas (eg, radiocephalic fistulas [6 versus 1 percent]). Hand ischemia from vascular steal may require a remedial procedures to reverse the ischemia to salvage the access or simple access ligation in severe cases. (See <a href=\"topic.htm?path=nonthrombotic-complications-of-arteriovenous-hemodialysis-access\" class=\"medical medical_review\">&quot;Nonthrombotic complications of arteriovenous hemodialysis access&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>High-output heart failure from AV fistulas occurs in less than 1 percent of case series. Thus, patients with heart failure are often not eligible for hemodialysis AV access. (See <a href=\"topic.htm?path=evaluation-and-management-of-heart-failure-caused-by-hemodialysis-arteriovenous-access\" class=\"medical medical_review\">&quot;Evaluation and management of heart failure caused by hemodialysis arteriovenous access&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Venous hypertension is usually related to central vein stenosis, which can lead to loss of the access if unrecognized and the lesion progresses to occlusion. (See <a href=\"topic.htm?path=central-vein-stenosis-associated-with-hemodialysis-access\" class=\"medical medical_review\">&quot;Central vein stenosis associated with hemodialysis access&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16443294\"><span class=\"h2\">Other issues</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anesthesia issues &ndash; AV fistulas can usually be constructed under local anesthesia. Transposed AV fistulas and AV grafts may require regional nerve blocks or general anesthesia due to the increased complexity of the operation. There is some evidence that brachial plexus blocks may be beneficial for vascular access operations by causing regional sympathetic blockade, which results in arterial and venous vasodilation. Some have also found that the venodilation caused by the regional block results in an increased incidence of AV fistula creation [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/70\" class=\"abstract_t\">70</a>]. In a randomized controlled study of infraclavicular brachial plexus block versus local infiltration anesthesia, patients in the block group had significantly higher rates of AV fistula blood flow eight weeks postoperatively than patients in the local anesthesia group [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/71\" class=\"abstract_t\">71</a>]. However, there was no difference in rates of early failure between the two groups, which may be due to the small sample size of 30 patients in each group. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nursing issues &ndash; AV fistulas may be more difficult to cannulate than AV grafts, particularly during initial use, and may explain why some staff in dialysis units actually prefer AV grafts [<a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/72\" class=\"abstract_t\">72</a>]. Experienced dialysis nurses and expert cannulation teams may be required to successfully cannulate new AV fistulas.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cosmetic issues &ndash; Excessive dilation of AV fistulas can be a major concern for patients. These issues should be addressed through education and should not prevent patients from receiving the benefits of a well-functioning AV fistula. (See <a href=\"topic.htm?path=nonthrombotic-complications-of-arteriovenous-hemodialysis-access#H12721750\" class=\"medical medical_review\">&quot;Nonthrombotic complications of arteriovenous hemodialysis access&quot;, section on 'Aneurysm/pseudoaneurysm'</a>.)</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=preparing-for-hemodialysis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Preparing for hemodialysis (The Basics)&quot;</a> and <a href=\"topic.htm?path=hemodialysis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Hemodialysis (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The three principal forms of chronic hemodialysis vascular access are arteriovenous (AV) fistulas, AV grafts, and hemodialysis catheters placed into a central vein. AV fistulas and AV grafts are deliberate connections between a native artery and vein. AV fistulas are constructed using a direct end-to-side vein-to-artery anastomosis. AV grafts are constructed by interposing a synthetic or other biologic conduit between an artery and vein. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"#H4247039902\" class=\"local\">'Arteriovenous hemodialysis access'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>AV fistulas are preferred over all other forms of chronic hemodialysis access because of a number of benefits. Mature AV fistulas are associated with decreased mortality and morbidity among hemodialysis patients compared with AV grafts and hemodialysis catheters. After AV fistulas, AV grafts are the next preferred long-term access. Hemodialysis catheters are consistently associated with the worst survival rates only be used as intermediate-duration vascular access, if necessary, while awaiting maturation of AV fistulas or AV grafts. (See <a href=\"#H568349\" class=\"local\">'Recommended strategy for chronic hemodialysis vascular access'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>To achieve a well-functioning AV access in advance of the anticipated initiation of dialysis, timely referral for surgery is important. The minimum time for AV fistula maturation is one month, but some may require up to six months, particularly if an adjunctive procedure (eg, angioplasty) is required to promote maturation. If an AV fistula is not possible, an AV graft can be considered. It is debatable whether a transposed brachiobasilic fistula should be offered before a lower forearm AV graft. (See <a href=\"#H4247039902\" class=\"local\">'Arteriovenous hemodialysis access'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>AV fistulas and AV grafts differ according to failure rates, time to use, patency, and types of perioperative and longer-term complications. AV fistulas are more likely than AV grafts to experience primary failure, defined as a fistula that never provided reliable access for hemodialysis. Despite this, the long-term patency of mature AV fistulas is superior to AV grafts. (See <a href=\"#H7\" class=\"local\">'Comparison of AV fistulas and AV grafts'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common complications of AV fistulas and AV grafts include thrombosis, infection, steal, aneurysms, venous hypertension, seromas, heart failure, and local bleeding. Thrombosis, infection, and seromas occur more frequently with AV grafts than with AV fistulas. (See <a href=\"#H13\" class=\"local\">'Complications'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/1\" class=\"nounderline abstract_t\">Oliver MJ, Rothwell DM, Fung K, et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15:1936.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/2\" class=\"nounderline abstract_t\">Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003; 42:1013.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/3\" class=\"nounderline abstract_t\">Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53:475.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/4\" class=\"nounderline abstract_t\">Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol 2013; 24:465.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/5\" class=\"nounderline abstract_t\">Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48 Suppl 1:S2.</a></li><li class=\"breakAll\">United States Renal Data System. 2014 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, 2014.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/7\" class=\"nounderline abstract_t\">Jindal K, Chan CT, Deziel C, et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17:S1.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/8\" class=\"nounderline abstract_t\">Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62:1109.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/9\" class=\"nounderline abstract_t\">Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial 2003; 16:189.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/10\" class=\"nounderline abstract_t\">Chan MR, Sanchez RJ, Young HN, Yevzlin AS. Vascular access outcomes in the elderly hemodialysis population: A USRDS study. Semin Dial 2007; 20:606.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/11\" class=\"nounderline abstract_t\">Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg 2007; 45:420.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/12\" class=\"nounderline abstract_t\">DeSilva RN, Patibandla BK, Vin Y, et al. Fistula first is not always the best strategy for the elderly. J Am Soc Nephrol 2013; 24:1297.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/13\" class=\"nounderline abstract_t\">Cui J, Steele D, Wenger J, et al. Hemodialysis arteriovenous fistula as first option not necessary in elderly patients. J Vasc Surg 2016; 63:1326.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/14\" class=\"nounderline abstract_t\">Wong CS, McNicholas N, Healy D, et al. A systematic review of preoperative duplex ultrasonography and arteriovenous fistula formation. J Vasc Surg 2013; 57:1129.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/15\" class=\"nounderline abstract_t\">Smith GE, Barnes R, Chetter IC. Randomized clinical trial of selective versus routine preoperative duplex ultrasound imaging before arteriovenous fistula surgery. Br J Surg 2014; 101:469.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/16\" class=\"nounderline abstract_t\">Lomonte C, Basile C. Preoperative assessment and planning of haemodialysis vascular access. Clin Kidney J 2015; 8:278.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/17\" class=\"nounderline abstract_t\">Wilson NA, Shenoy S. Ultrasound in preoperative evaluation for dialysis-access placement. Semin Dial 2014; 27:593.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/18\" class=\"nounderline abstract_t\">Allon M, Lockhart ME, Lilly RZ, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 2001; 60:2013.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/19\" class=\"nounderline abstract_t\">Asif A, Cherla G, Merrill D, et al. Conversion of tunneled hemodialysis catheter-consigned patients to arteriovenous fistula. Kidney Int 2005; 67:2399.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/20\" class=\"nounderline abstract_t\">Chin AI, Chang W, Fitzgerald JT, et al. Intra-access blood flow in patients with newly created upper-arm arteriovenous native fistulae for hemodialysis access. Am J Kidney Dis 2004; 44:850.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/21\" class=\"nounderline abstract_t\">Gradman WS, Laub J, Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg 2005; 41:279.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/22\" class=\"nounderline abstract_t\">Lawson JH, Glickman MH, Ilzecki M, et al. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet 2016; 387:2026.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/23\" class=\"nounderline abstract_t\">Hurt AV, Batello-Cruz M, Skipper BJ, et al. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study. Am J Surg 1983; 146:844.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/24\" class=\"nounderline abstract_t\">Liu Z, Zhu B, Wang X, et al. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. Kidney Int 2007; 72:1249.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/25\" class=\"nounderline abstract_t\">Canaud B. Formaldehyde-fixed arterial allograft as a novel vascular access alternative in end-stage renal disease patients. Kidney Int 2007; 72:1179.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/26\" class=\"nounderline abstract_t\">Hurlbert SN, Mattos MA, Henretta JP, et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: a prospective study that compares Impra versus Gore-tex grafts. Cardiovasc Surg 1998; 6:652.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/27\" class=\"nounderline abstract_t\">Lenz BJ, Veldenz HC, Dennis JW, et al. A three-year follow-up on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 1998; 28:464.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/28\" class=\"nounderline abstract_t\">Schuman ES, Standage BA, Ragsdale JW, Gross GF. Reinforced versus nonreinforced polytetrafluoroethylene grafts for hemodialysis access. Am J Surg 1997; 173:407.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/29\" class=\"nounderline abstract_t\">Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol 2003; 14:2942.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/30\" class=\"nounderline abstract_t\">Ram SJ, Sachdeva BA, Caldito GC, et al. Thigh grafts contribute significantly to patients' time on dialysis. Clin J Am Soc Nephrol 2010; 5:1229.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/31\" class=\"nounderline abstract_t\">Miller PE, Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56:275.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/32\" class=\"nounderline abstract_t\">Rodriguez JA, Armadans L, Ferrer E, et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15:402.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/33\" class=\"nounderline abstract_t\">Monroy-Cuadros M, Yilmaz S, Salazar-Ba&ntilde;uelos A, Doig C. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol 2010; 5:1787.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/34\" class=\"nounderline abstract_t\">Silva MB Jr, Hobson RW 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27:302.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/35\" class=\"nounderline abstract_t\">Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63:346.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/36\" class=\"nounderline abstract_t\">Obialo CI, Tagoe AT, Martin PC, Asche-Crowe PE. Adequacy and survival of autogenous arteriovenous fistula in African American hemodialysis patients. ASAIO J 2003; 49:435.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/37\" class=\"nounderline abstract_t\">Segal JH, Kayler LK, Henke P, et al. Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis 2003; 42:151.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/38\" class=\"nounderline abstract_t\">Ravani P, Brunori G, Mandolfo S, et al. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15:204.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/39\" class=\"nounderline abstract_t\">van der Linden J, Lameris TW, van den Meiracker AH, et al. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47:1013.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/40\" class=\"nounderline abstract_t\">Lee T, Barker J, Allon M. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol 2007; 18:1936.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/41\" class=\"nounderline abstract_t\">Lockhart ME, Robbin ML, McNamara MM, Allon M. Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients. Nephrol Dial Transplant 2004; 19:2564.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/42\" class=\"nounderline abstract_t\">Lok CE, Allon M, Moist L, et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17:3204.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/43\" class=\"nounderline abstract_t\">Huijbregts HJ, Bots ML, Wittens CH, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008; 3:714.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/44\" class=\"nounderline abstract_t\">Al-Jaishi AA, Oliver MJ, Thomas SM, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 2014; 63:464.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/45\" class=\"nounderline abstract_t\">Sands J, Miranda CL. Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol 1997; 48:114.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/46\" class=\"nounderline abstract_t\">Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299:2164.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/47\" class=\"nounderline abstract_t\">Dunlop MG, Mackinlay JY, Jenkins AM. Vascular access: experience with the brachiocephalic fistula. Ann R Coll Surg Engl 1986; 68:203.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/48\" class=\"nounderline abstract_t\">Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 1999; 33:910.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/49\" class=\"nounderline abstract_t\">Konner K, Hulbert-Shearon TE, Roys EC, Port FK. Tailoring the initial vascular access for dialysis patients. Kidney Int 2002; 62:329.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/50\" class=\"nounderline abstract_t\">Faiyaz R, Abreo K, Zaman F, et al. Salvage of poorly developed arteriovenous fistulae with percutaneous ligation of accessory veins. Am J Kidney Dis 2002; 39:824.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/51\" class=\"nounderline abstract_t\">Falk A, Teodorescu V, Lou WY, et al. Treatment of &quot;swing point stenoses&quot; in hemodialysis arteriovenous fistulae. Clin Nephrol 2003; 60:35.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/52\" class=\"nounderline abstract_t\">Beathard GA, Arnold P, Jackson J, et al. Aggressive treatment of early fistula failure. Kidney Int 2003; 64:1487.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/53\" class=\"nounderline abstract_t\">Nassar GM, Nguyen B, Rhee E, Achkar K. Endovascular treatment of the &quot;failing to mature&quot; arteriovenous fistula. Clin J Am Soc Nephrol 2006; 1:275.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/54\" class=\"nounderline abstract_t\">Almasri J, Alsawas M, Mainou M, et al. Outcomes of vascular access for hemodialysis: A&nbsp;systematic review and meta-analysis. J Vasc Surg 2016; 64:236.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/55\" class=\"nounderline abstract_t\">Munda R, First MR, Alexander JW, et al. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983; 249:219.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/56\" class=\"nounderline abstract_t\">Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 2003; 38:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/57\" class=\"nounderline abstract_t\">Sottiurai VS, Stephens A, Champagne L, et al. Comparative results of early and delayed cannulation of arteriovenous graft in haemodialysis. Eur J Vasc Endovasc Surg 1997; 13:139.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/58\" class=\"nounderline abstract_t\">Schild AF, Schuman ES, Noicely K, et al. Early cannulation prosthetic graft (Flixene&trade;) for arteriovenous access. J Vasc Access 2011; 12:248.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/59\" class=\"nounderline abstract_t\">Saran R, Pisoni RL, Young EW. Timing of first cannulation of arteriovenous fistula: are we waiting too long? Nephrol Dial Transplant 2005; 20:688.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/60\" class=\"nounderline abstract_t\">Rayner HC, Pisoni RL, Gillespie BW, et al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63:323.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/61\" class=\"nounderline abstract_t\">Saran R, Dykstra DM, Pisoni RL, et al. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant 2004; 19:2334.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/62\" class=\"nounderline abstract_t\">Brunori G, Ravani P, Mandolfo S, et al. Fistula maturation: doesn't time matter at all? Nephrol Dial Transplant 2005; 20:684.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/63\" class=\"nounderline abstract_t\">Young EW, Dykstra DM, Goodkin DA, et al. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61:2266.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/64\" class=\"nounderline abstract_t\">Polo JR, Tejedor A, Polo J, et al. Long-term follow-up of 6-8 mm brachioaxillary polytetrafluorethylene grafts for hemodialysis. Artif Organs 1995; 19:1181.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/65\" class=\"nounderline abstract_t\">Bender MH, Bruyninckx CM, Gerlag PG. The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. J Vasc Surg 1994; 20:808.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/66\" class=\"nounderline abstract_t\">Hodges TC, Fillinger MF, Zwolak RM, et al. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 1997; 26:1009.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/67\" class=\"nounderline abstract_t\">Coburn MC, Carney WI Jr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994; 20:896.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/68\" class=\"nounderline abstract_t\">Mudoni A, Cornacchiari M, Gallieni M, et al. Aneurysms and pseudoaneurysms in dialysis access. Clin Kidney J 2015; 8:363.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/69\" class=\"nounderline abstract_t\">Salahi H, Fazelzadeh A, Mehdizadeh A, et al. Complications of arteriovenous fistula in dialysis patients. Transplant Proc 2006; 38:1261.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/70\" class=\"nounderline abstract_t\">Reynolds TS, Kim KM, Dukkipati R, et al. Pre-operative regional block anesthesia enhances operative strategy for arteriovenous fistula creation. J Vasc Access 2011; 12:336.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/71\" class=\"nounderline abstract_t\">Sahin L, Gul R, Mizrak A, et al. Ultrasound-guided infraclavicular brachial plexus block enhances postoperative blood flow in arteriovenous fistulas. J Vasc Surg 2011; 54:749.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-chronic-hemodialysis-vascular-access/abstract/72\" class=\"nounderline abstract_t\">Bay WH, Van Cleef S, Owens M. The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol 1998; 18:379.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1984 Version 22.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H24\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H568349\" id=\"outline-link-H568349\">RECOMMENDED STRATEGY FOR CHRONIC HEMODIALYSIS VASCULAR ACCESS</a></li><li><a href=\"#H4247039902\" id=\"outline-link-H4247039902\">ARTERIOVENOUS HEMODIALYSIS ACCESS</a><ul><li><a href=\"#H2288150280\" id=\"outline-link-H2288150280\">Arteriovenous fistulas</a></li><li><a href=\"#H808138106\" id=\"outline-link-H808138106\">Arteriovenous grafts</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">COMPARISON OF AV FISTULAS AND AV GRAFTS</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Primary failure</a></li><li><a href=\"#H571247\" id=\"outline-link-H571247\">Patency</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Time to first cannulation</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Complications</a></li><li><a href=\"#H16443294\" id=\"outline-link-H16443294\">Other issues</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H11343243\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=arteriovenous-fistula-creation-for-hemodialysis-and-its-complications\" class=\"medical medical_review\">Arteriovenous fistula creation for hemodialysis and its complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=arteriovenous-graft-creation-for-hemodialysis-and-its-complications\" class=\"medical medical_review\">Arteriovenous graft creation for hemodialysis and its complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=central-catheters-for-acute-and-chronic-hemodialysis-access\" class=\"medical medical_review\">Central catheters for acute and chronic hemodialysis access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=central-vein-stenosis-associated-with-hemodialysis-access\" class=\"medical medical_review\">Central vein stenosis associated with hemodialysis access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endovascular-intervention-for-the-treatment-of-stenosis-in-the-arteriovenous-access\" class=\"medical medical_review\">Endovascular intervention for the treatment of stenosis in the arteriovenous access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-management-of-heart-failure-caused-by-hemodialysis-arteriovenous-access\" class=\"medical medical_review\">Evaluation and management of heart failure caused by hemodialysis arteriovenous access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=failure-of-the-mature-hemodialysis-arteriovenous-fistula\" class=\"medical medical_review\">Failure of the mature hemodialysis arteriovenous fistula</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hemodialysis-arteriovenous-graft-dysfunction-and-failure\" class=\"medical medical_review\">Hemodialysis arteriovenous graft dysfunction and failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=maturation-and-evaluation-of-the-newly-created-hemodialysis-arteriovenous-fistula\" class=\"medical medical_review\">Maturation and evaluation of the newly created hemodialysis arteriovenous fistula</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nonthrombotic-complications-of-arteriovenous-hemodialysis-access\" class=\"medical medical_review\">Nonthrombotic complications of arteriovenous hemodialysis access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hemodialysis-the-basics\" class=\"medical medical_basics\">Patient education: Hemodialysis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preparing-for-hemodialysis-the-basics\" class=\"medical medical_basics\">Patient education: Preparing for hemodialysis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=patient-evaluation-and-vascular-mapping-prior-to-placement-of-hemodialysis-arteriovenous-access\" class=\"medical medical_review\">Patient evaluation and vascular mapping prior to placement of hemodialysis arteriovenous access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-failure-of-the-hemodialysis-arteriovenous-fistula\" class=\"medical medical_review\">Primary failure of the hemodialysis arteriovenous fistula</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=risk-factors-for-hemodialysis-arteriovenous-fistula-failure\" class=\"medical medical_review\">Risk factors for hemodialysis arteriovenous fistula failure</a></li></ul></div></div>","javascript":null}